Please see the Important Safety Information and the full U.S. Prescribing Information below. Colorectal cancer is the second leading cause of cancer-related deaths in the United States. The American ...

Please provide your email address to receive an email when new articles are posted on . “What we found with this prep, which is the lowest volume prep on the market today, is that patients were quite ...

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Valeant Pharmaceuticals (NYSE: VRX) subsidary Salix Pharmaceuticals, Ltd. and its partner Norgine B.V. announced ...

Valeant Pharmaceuticals International, wholly owned subsidiary, Salix Pharmaceuticals, announced that the US Food and Drug Administration (FDA) accepted the New Drug Application for NER1006 (Plenvu) a ...

Colonoscopies are never fun. But they are necessary to help catch colon cancer. Now the U.S. Food and Drug Administration has approved a new drug that could make preparation for the screening easier.

The approval of Plenvu was based on multiple clinical trials including the NOCT study which compared Plenvu to the trisulfate bowel cleansing solution Suprep (sodium sulfate, potassium sulfate, ...

BRIDGEWATER, N.J., Sept. 11, 2018 /CNW/ -- Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of ...